Suppr超能文献

FLT3 基因内串联重复突变通过阻断 Rho 相关激酶的下调,增强了对 Cxcl12 蛋白的趋化作用,该过程通过 Cxcl12/Cxcr4 信号轴发生。

Internal tandem duplication mutations in FLT3 gene augment chemotaxis to Cxcl12 protein by blocking the down-regulation of the Rho-associated kinase via the Cxcl12/Cxcr4 signaling axis.

机构信息

From the Departments of Oncology/Hematology and

Pediatrics and.

出版信息

J Biol Chem. 2014 Nov 7;289(45):31053-65. doi: 10.1074/jbc.M114.568287. Epub 2014 Sep 18.

Abstract

Internal tandem duplication mutations in the Flt3 gene (ITD-FLT3) enhance cell migration toward the chemokine Cxcl12, which is highly expressed in the therapy-protective bone marrow niche, providing a potential mechanism underlying the poor prognosis of ITD-FLT3(+) acute myeloid leukemia. We aimed to investigate the mechanisms linking ITD-FLT3 to increased cell migration toward Cxcl12. Classification of the expression of Cxcl12-regulated genes in ITD-FLT3(+) cells demonstrated that the enhanced migration of ITD-FLT3(+) cells toward Cxcl12 was associated with the differential expression of genes downstream of Cxcl12/Cxcr4, which are functionally distinct from those expressed in ITD-FLT3(-) cells but are independent of the Cxcr4 expression levels. Among these differentially regulated genes, the expression of Rock1 in the ITD-FLT3(+) cells that migrated toward Cxcl12 was significantly higher than in ITD-FLT3(-) cells that migrated toward Cxcl12. In ITD-FLT3(-) cells, Rock1 expression and Mypt1 phosphorylation were transiently up-regulated but were subsequently down-regulated by Cxcl12. In contrast, the presence of ITD-FLT3 blocked the Cxcl12-induced down-regulation of Rock1 and early Mypt1 dephosphorylation. Likewise, the FLT3 ligand counteracted the Cxcl12-induced down-regulation of Rock1 in ITD-FLT3(-) cells, which coincided with enhanced cell migration toward Cxcl12. Rock1 antagonists or Rock1 shRNA abolished the enhanced migration of ITD-FLT3(+) cells toward Cxcl12. Our findings demonstrate that ITD-FLT3 increases cell migration toward Cxcl12 by antagonizing the down-regulation of Rock1 expression. These findings suggest that the aberrant modulation of Rock1 expression and activity induced by ITD-FLT3 may enhance acute myeloid leukemia cell chemotaxis to the therapy-protective bone marrow niche, where Cxcl12 is abundantly expressed.

摘要

Flt3 基因内串联重复突变(ITD-FLT3)增强了细胞向趋化因子 Cxcl12 的迁移能力,Cxcl12 在具有治疗保护作用的骨髓龛中高度表达,为 ITD-FLT3(+)急性髓系白血病不良预后提供了潜在机制。我们旨在研究将 ITD-FLT3 与趋化因子 Cxcl12 诱导的细胞迁移增加联系起来的机制。对 ITD-FLT3(+)细胞中 Cxcl12 调节基因的表达进行分类,表明 ITD-FLT3(+)细胞向 Cxcl12 的迁移增强与 Cxcl12/Cxcr4 下游基因的差异表达有关,这些基因的功能与 ITD-FLT3(-)细胞表达的基因不同,但独立于 Cxcr4 表达水平。在这些差异调节的基因中,向 Cxcl12 迁移的 ITD-FLT3(+)细胞中 Rock1 的表达明显高于向 Cxcl12 迁移的 ITD-FLT3(-)细胞。在 ITD-FLT3(-)细胞中,Rock1 表达和 Mypt1 磷酸化短暂上调,但随后被 Cxcl12 下调。相比之下,ITD-FLT3 的存在阻止了 Cxcl12 诱导的 Rock1 下调和早期 Mypt1 去磷酸化。同样,FLT3 配体抵消了 ITD-FLT3(-)细胞中 Cxcl12 诱导的 Rock1 下调,同时增强了向 Cxcl12 的细胞迁移。Rock1 拮抗剂或 Rock1 shRNA 消除了 ITD-FLT3(+)细胞向 Cxcl12 的增强迁移。我们的研究结果表明,ITD-FLT3 通过拮抗 Rock1 表达的下调增加了细胞向 Cxcl12 的迁移。这些发现表明,ITD-FLT3 引起的 Rock1 表达和活性的异常调节可能增强急性髓系白血病细胞向富含 Cxcl12 的治疗保护骨髓龛的趋化作用。

相似文献

3
Flt3 ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1alpha(CXCL12)/CXCR4 axis.
Blood. 2005 Apr 15;105(8):3117-26. doi: 10.1182/blood-2004-04-1440. Epub 2004 Dec 23.
6
Impact of CXCR4 inhibition on FLT3-ITD-positive human AML blasts.
Exp Hematol. 2010 Mar;38(3):180-90. doi: 10.1016/j.exphem.2009.12.003. Epub 2009 Dec 24.
8
The magnitude of CXCR4 signaling regulates resistance to quizartinib in FLT3/ITD cells via RUNX1.
Leuk Res. 2023 Jan;124:106983. doi: 10.1016/j.leukres.2022.106983. Epub 2022 Oct 29.
9
Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.
Blood. 2009 Jun 11;113(24):6215-24. doi: 10.1182/blood-2008-05-158311. Epub 2008 Oct 27.

引用本文的文献

1
Leukemic Stem Cells and Hematological Malignancies.
Int J Mol Sci. 2024 Jun 17;25(12):6639. doi: 10.3390/ijms25126639.
2
Overcoming Resistance: FLT3 Inhibitors Past, Present, Future and the Challenge of Cure.
Cancers (Basel). 2022 Sep 2;14(17):4315. doi: 10.3390/cancers14174315.
3
Target Therapy for Extramedullary Relapse of -ITD Acute Myeloid Leukemia: Emerging Data from the Field.
Cancers (Basel). 2022 Apr 27;14(9):2186. doi: 10.3390/cancers14092186.
4
Mechanisms of resistance to targeted therapies for relapsed or refractory acute myeloid leukemia.
Exp Hematol. 2022 Jul;111:13-24. doi: 10.1016/j.exphem.2022.04.001. Epub 2022 Apr 10.
6
Novel Approaches to Target Mutant FLT3 Leukaemia.
Cancers (Basel). 2020 Sep 29;12(10):2806. doi: 10.3390/cancers12102806.
8
Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia.
Ther Adv Hematol. 2019 Feb 15;10:2040620719827310. doi: 10.1177/2040620719827310. eCollection 2019.
9
ROCK regulates the intermittent mode of interstitial T cell migration in inflamed lungs.
Nat Commun. 2017 Oct 18;8(1):1010. doi: 10.1038/s41467-017-01032-2.

本文引用的文献

1
Thiamine deficiency promotes T cell infiltration in experimental autoimmune encephalomyelitis: the involvement of CCL2.
J Immunol. 2014 Sep 1;193(5):2157-67. doi: 10.4049/jimmunol.1302702. Epub 2014 Jul 25.
2
CXCR4, but not CXCR7, discriminates metastatic behavior in non-small cell lung cancer cells.
Mol Cancer Res. 2014 Jan;12(1):38-47. doi: 10.1158/1541-7786.MCR-12-0334. Epub 2013 Sep 11.
3
Double-blind, placebo-controlled clinical trial with a rho-kinase inhibitor in pulmonary arterial hypertension.
Circ J. 2013;77(10):2619-25. doi: 10.1253/circj.cj-13-0443. Epub 2013 Aug 3.
4
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.
Nature. 2012 Apr 15;485(7397):260-3. doi: 10.1038/nature11016.
5
Synthesis, modeling and functional activity of substituted styrene-amides as small-molecule CXCR7 agonists.
Eur J Med Chem. 2012 May;51:184-92. doi: 10.1016/j.ejmech.2012.02.041. Epub 2012 Feb 27.
6
A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia.
Blood. 2012 Apr 26;119(17):3917-24. doi: 10.1182/blood-2011-10-383406. Epub 2012 Feb 2.
8
Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity.
Cytoskeleton (Hoboken). 2010 Sep;67(9):545-54. doi: 10.1002/cm.20472.
9
Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML.
Nat Biotechnol. 2010 Mar;28(3):275-80. doi: 10.1038/nbt.1607. Epub 2010 Feb 14.
10
Dynamic regulation of ROCK in tumor cells controls CXCR4-driven adhesion events.
J Cell Sci. 2010 Feb 1;123(Pt 3):401-12. doi: 10.1242/jcs.052167. Epub 2010 Jan 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验